Authors:
BENSADOUN JC
MIROCHNITCHENKO O
INOUYE M
AEBISCHER P
ZURN AD
Citation: Jc. Bensadoun et al., ATTENUATION OF 6-OHDA-INDUCED NEUROTOXICITY IN GLUTATHIONE-PEROXIDASETRANSGENIC MICE, European journal of neuroscience, 10(10), 1998, pp. 3231-3236
Authors:
DECOSTERD I
BUCHSER E
GILLIARD N
SAYDOFF J
ZURN AD
AEBISCHER P
Citation: I. Decosterd et al., INTRATHECAL IMPLANTS OF BOVINE CHROMAFFIN CELLS ALLEVIATE MECHANICAL ALLODYNIA IN A RAT MODEL OF NEUROPATHIC PAIN, Pain, 76(1-2), 1998, pp. 159-166
Authors:
SAUTTER J
TSENG JL
BRAGUGLIA D
AEBISCHER P
SPENGER C
SEILER RW
WIDMER HR
ZURN AD
Citation: J. Sautter et al., IMPLANTS OF POLYMER-ENCAPSULATED GENETICALLY-MODIFIED CELLS RELEASINGGLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR IMPROVE SURVIVAL, GROWTH,AND FUNCTION OF FETAL DOPAMINERGIC GRAFTS, Experimental neurology, 149(1), 1998, pp. 230-236
Authors:
HOTTINGER AF
FINE EG
GURNEY ME
ZURN AD
AEBISCHER P
Citation: Af. Hottinger et al., THE COPPER CHELATOR D-PENICILLAMINE DELAYS ONSET OF DISEASE AND EXTENDS SURVIVAL IN A TRANSGENIC MOUSE MODEL OF FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS, European journal of neuroscience, 9(7), 1997, pp. 1548-1551
Authors:
POCHON NAM
MENOUD A
TSENG JL
ZURN AD
AEBISCHER P
Citation: Nam. Pochon et al., NEURONAL GDNF EXPRESSION IN THE ADULT-RAT NERVOUS-SYSTEM IDENTIFIED BY IN-SITU HYBRIDIZATION, European journal of neuroscience, 9(3), 1997, pp. 463-471
Citation: Jl. Tseng et al., GDNF REDUCES DRUG-INDUCED ROTATIONAL BEHAVIOR AFTER MEDIAL FOREBRAIN-BUNDLE TRANSECTION BY A MECHANISM NOT INVOLVING STRIATAL DOPAMINE, The Journal of neuroscience, 17(1), 1997, pp. 325-333
Authors:
AEBISCHER P
SCHLUEP M
DEGLON N
JOSEPH JM
HIRT L
HEYD B
GODDARD M
HAMMANG JP
ZURN AD
KATO AC
REGLI F
BAETGE EE
Citation: P. Aebischer et al., INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS (VOL 2, PG 696, 1996), Nature medicine, 2(9), 1996, pp. 1041-1041
Authors:
AEBISCHER P
SCHLUEP M
DEGLON N
JOSEPH JM
HIRT L
HEYD B
GODDARD M
HAMMANG JP
ZURN AD
KATO AC
REGLI F
BAETGE EE
Citation: P. Aebischer et al., INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS, Nature medicine, 2(6), 1996, pp. 696-699
Authors:
AEBISCHER P
POCHON NAM
HEYD B
DEGLON N
JOSEPH JM
ZURN AD
BAETGE EE
HAMMANG JP
GODDARD M
LYSAGHT M
KAPLAN F
KATO AC
SCHLUEP M
HIRT L
REGLI F
PORCHET F
DETRIBOLET N
Citation: P. Aebischer et al., GENE-THERAPY FOR AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) USING A POLYMER ENCAPSULATED XENOGENIC CELL-LINE ENGINEERED TO SECRETE HCNTF, Human gene therapy, 7(7), 1996, pp. 851-860
Authors:
DEGLON N
HEYD B
TAN SA
JOSEPH JM
ZURN AD
AEBISCHER P
Citation: N. Deglon et al., CENTRAL-NERVOUS-SYSTEM DELIVERY OF RECOMBINANT CILIARY NEUROTROPHIC FACTOR BY POLYMER ENCAPSULATED DIFFERENTIATED C2C12 MYOBLASTS, Human gene therapy, 7(17), 1996, pp. 2135-2146
Authors:
TAN SA
DEGLON N
ZURN AD
BAETGE EE
BAMBER B
KATO AC
AEBISCHER P
Citation: Sa. Tan et al., RESCUE OF MOTONEURONS FROM AXOTOMY-INDUCED CELL-DEATH BY POLYMER ENCAPSULATED CELLS GENETICALLY-ENGINEERED TO RELEASE CNTF, Cell transplantation, 5(5), 1996, pp. 577-587
Authors:
ZURN AD
WINKEL L
MENOUD A
DJABALI K
AEBISCHER P
Citation: Ad. Zurn et al., COMBINED EFFECTS OF GDNF, BDNF, AND CNTF ON MOTONEURON DIFFERENTIATION IN-VITRO, Journal of neuroscience research, 44(2), 1996, pp. 133-141
Authors:
ZURN AD
BAETGE EE
HAMMANG JP
TAN SA
AEBISCHER P
Citation: Ad. Zurn et al., GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF), A NEW NEUROTROPHIC FACTOR FOR MOTONEURONS, NeuroReport, 6(1), 1994, pp. 113-118
Citation: Ad. Zurn et F. Werren, DEVELOPMENT OF CNS CHOLINERGIC NEURONS IN-VITRO - SELECTIVE EFFECTS OF CNTF AND LIF ON NEURONS FROM MESENCEPHALIC CRANIAL MOTOR NUCLEI, Developmental biology, 163(2), 1994, pp. 309-315
Citation: Ad. Zurn et al., THE NEUROPEPTIDE VIP REGULATES THE EXPRESSION OF THE TYROSINE-HYDROXYLASE GENE IN CULTURED AVIAN SYMPATHETIC NEURONS, Molecular brain research, 20(1-2), 1993, pp. 125-129